Compare Honeywell International Inc (HON) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Illumina, Inc. — how do they compare? Honeywell International Inc trades at $229.96 (market cap $71.66B), while Illumina, Inc. trades at $192.47 (market cap $27.94B). The key difference: Honeywell International Inc is far larger — about 2.6× Illumina, Inc.'s market cap, and Honeywell International Inc pays a 4.21% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| HON | ILMN | |
|---|---|---|
Market Cap | $71.66B | $27.94B |
Sector | Industrials | Health |
52-Week High | $248.04 | $194.33 |
52-Week Low | $188.14 | $91.00 |
Enterprise Value | $96.01B | $29.33B |
Dividend Yield | 4.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
